Postcoid syndrome in 70% of patients manifests itself as impaired lung function, including shortness of breath and non-restoring oxygen saturation, RIA Novosti reported, citing an infectious disease doctor, chief physician of the Invitro-Siberia clinical diagnostic laboratory Andrei Pozdnyakov.
“Next comes asthenovegetative syndrome, a nervous disorder that includes increased fatigue, irritability, decreased concentration and, as a result, a decrease in the quality of life in general. Various functional and neurological disorders occur in 50-60% of patients with postcoid syndrome, ”Pozdnyakov said.
Not all patients with coronavirus develop a post-coccygeal symptom, but it can appear even after asymptomatic and mild COVID-19. On average, this syndrome lasts 4-4.5 months from the onset of symptoms.
Approximately 30% of patients develop persistent neurological disorders, 20-25% – damage to the lining of the heart or myocardium, 50% – vascular damage, 25-30% – gastrointestinal disorders, including disorders of the liver and pancreas. The course of COVID-19 does not directly affect the severity of postcoid syndrome, the doctor added. Already “compromised” organs and systems suffer more often.
“One of the factors that influences the development of postcoid syndrome is immunity. A person with a weak immune response is more likely to carry the coronavirus easily, because the body will not overreact and overreact. But the same weak immune response contributes to the long stay of the virus in the body. This means that a virus for a longer period can contribute to damage to systems and organs, ”Pozdnyakov explained.
A marker of postcoid syndrome is an increase in the level of antibodies upon repeated analysis. However, the most difficult thing in terms of diagnosis is neurological manifestations that cannot be detected either by laboratory or instrumental methods.
.